ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 2888

$919K Total Retail Price of All Prescriptions

Rank: 256 out of 2888

288 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 288 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

27% of this provider’s 288 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,571 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 568 512 1 1
FUROSEMIDE 483 429 2 6
LISINOPRIL 478 392 3 3
POTASSIUM CHLORIDE 450 389 4 14
OMEPRAZOLE 374 357 5 7
DONEPEZIL HCL 355 341 6 26
NAMENDA 353 341 7 34
HYDROCODONE-ACETAMINOPHEN 334 265 S3 8 4
AMLODIPINE BESYLATE 306 282 9 5
METOPROLOL TARTRATE 302 259 10 10
CYMBALTA 254 167 11 44
TRAMADOL HCL 250 214 12 16
SIMVASTATIN 221 207 13 2
GABAPENTIN 217 166 14 13
ALENDRONATE SODIUM 214 180 15 23
METFORMIN HCL 186 133 16 8
NOVOLIN R 180 149 17 109
SERTRALINE HCL 170 142 18 27
WARFARIN SODIUM 149 129 19 22
HYDROCHLOROTHIAZIDE 148 119 20 15
MIRTAZAPINE 137 103 21 54
MELOXICAM 121 120 22 31
ALBUTEROL SULFATE 120 58 23 134
GLYBURIDE 120 84 R 23 58
LACTULOSE 120 55 23 111
RISPERIDONE 118 100 26 72
OLANZAPINE 118 80 26 137
ABILIFY 117 61 28 172
PRAVASTATIN SODIUM 111 85 29 12
CLOPIDOGREL 108 91 30 30
IPRATROPIUM BROMIDE 108 43 30 188
LANTUS 107 71 32 45
JANUVIA 106 103 33 48
METOPROLOL SUCCINATE 105 92 34 11
NEXIUM 97 54 35 19
BACLOFEN 93 30 36 121
OXYBUTYNIN CHLORIDE ER 90 77 37 132
DIGOXIN 89 77 38 55
PLAVIX 86 73 39 40
ESCITALOPRAM OXALATE 83 44 40 62
ATENOLOL 82 59 41 25
TAMSULOSIN HCL 80 65 42 29
ALLOPURINOL 80 75 42 37
ATORVASTATIN CALCIUM 76 71 44 9
EXELON 75 63 45 106
OXYBUTYNIN CHLORIDE 75 71 45 124
POLYETHYLENE GLYCOL 3350 69 69 47 93
ADVAIR DISKUS 68 48 48 60
CARBIDOPA-LEVODOPA 66 66 49 113
ZOLPIDEM TARTRATE 63 42 50 17
BENZTROPINE MESYLATE 63 35 R 50 191
GLIPIZIDE 62 29 52 50
SINGULAIR 61 42 53 85
RANITIDINE HCL 61 59 53 56
ROPINIROLE HCL 59 50 55 115
SPIRONOLACTONE 59 37 55 70
GEMFIBROZIL 58 35 57 98
LEVETIRACETAM 57 43 58 103
LOVASTATIN 55 54 59 41
DETROL LA 55 55 59 192
ENALAPRIL MALEATE 54 50 61 49
CLONIDINE HCL 53 35 62 39
CRESTOR 53 53 62 20
TRIAMTERENE-HCTZ 52 44 64 63
BUSPIRONE HCL 51 37 65 148
SPIRIVA 50 38 66 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 35 66 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.